Skip to main content
. Author manuscript; available in PMC: 2011 Oct 26.
Published in final edited form as: Tissue Eng. 2006 May;12(5):1313–1323. doi: 10.1089/ten.2006.12.1313

FIG. 8.

FIG. 8

Effect of BAL treatment on animal survival in fulminant hepatic failure rats. Survival curves of the no cell AdIL-1Ra(–), porcine AdIL-1Ra(–), no cell rIL-1Ra(+), and porcine AdIL-1Ra(+) groups. No cell AdIL-1Ra(–), no cells in the BAL device; porcine AdIL-1Ra(–), non-transfected porcine hepatocytes in the BAL device; no cell rIL-1Ra(+), BAL device without cells but recombinant human IL-1Ra was continuously infused through a venous line; porcine AdIL-1Ra(+), porcine hepatocytes transfected with adenoviral vector encoding human IL-1Ra. IL-1Ra, interleukin-1 receptor antagonist; GalN, D-galactosamine; BAL, bioartificial liver.